BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27035952)

  • 1. Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.
    Thell K; Hellinger R; Sahin E; Michenthaler P; Gold-Binder M; Haider T; Kuttke M; Liutkevičiūtė Z; Göransson U; Gründemann C; Schabbauer G; Gruber CW
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):3960-5. PubMed ID: 27035952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism.
    Gründemann C; Thell K; Lengen K; Garcia-Käufer M; Huang YH; Huber R; Craik DJ; Schabbauer G; Gruber CW
    PLoS One; 2013; 8(6):e68016. PubMed ID: 23840803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory effects of cyclotides isolated from Viola odorata in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis.
    Dayani L; Dinani MS; Aliomrani M; Hashempour H; Varshosaz J; Taheri A
    Mult Scler Relat Disord; 2022 Aug; 64():103958. PubMed ID: 35716476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma.
    Lind J; Hellinger R; Kudweis P; Moll HP; Gattringer J; Thell K; Edtmayer S; Gruber CW; Stoiber D; Kollmann K
    Biomed Pharmacother; 2022 Sep; 153():113486. PubMed ID: 36076504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant-based production of an orally active cyclotide for the treatment of multiple sclerosis.
    Jackson MA; Xie J; Nguyen LTT; Wang X; Yap K; Harvey PJ; Gilding EK; Craik DJ
    Transgenic Res; 2023 Apr; 32(1-2):121-133. PubMed ID: 36930229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.
    Touil T; Ciric B; Ventura E; Shindler KS; Gran B; Rostami A
    J Neurol Sci; 2008 Aug; 271(1-2):191-202. PubMed ID: 18544456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions.
    Dagkonaki A; Avloniti M; Evangelidou M; Papazian I; Kanistras I; Tseveleki V; Lampros F; Tselios T; Jensen LT; Möbius W; Ruhwedel T; Androutsou ME; Matsoukas J; Anagnostouli M; Lassmann H; Probert L
    Front Immunol; 2020; 11():575451. PubMed ID: 33329540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of experimental autoimmune encephalitis by novel peptides: involvement of T regulatory cells.
    Shapira E; Brodsky B; Proscura E; Nyska A; Erlanger-Rosengarten A; Wormser U
    J Autoimmun; 2010 Aug; 35(1):98-106. PubMed ID: 20434883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.
    Virgili N; Espinosa-Parrilla JF; Mancera P; Pastén-Zamorano A; Gimeno-Bayon J; Rodríguez MJ; Mahy N; Pugliese M
    J Neuroinflammation; 2011 Nov; 8():149. PubMed ID: 22047130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.
    Trager N; Smith A; Wallace Iv G; Azuma M; Inoue J; Beeson C; Haque A; Banik NL
    J Neurochem; 2014 Jul; 130(2):268-79. PubMed ID: 24447070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis.
    Crespo O; Kang SC; Daneman R; Lindstrom TM; Ho PP; Sobel RA; Steinman L; Robinson WH
    J Clin Immunol; 2011 Dec; 31(6):1010-20. PubMed ID: 21847523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate alleviates the symptoms of experimental autoimmune encephalomyelitis.
    Jung K; Kim J; Ahn G; Matsuda H; Akane T; Ahn M; Shin T
    Int Immunopharmacol; 2020 Jul; 84():106534. PubMed ID: 32361191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
    Luccarini I; Ballerini C; Biagioli T; Biamonte F; Bellucci A; Rosi MC; Grossi C; Massacesi L; Casamenti F
    Exp Neurol; 2008 May; 211(1):214-26. PubMed ID: 18346732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
    Mondal S; Pahan K
    PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant derived cyclic peptides.
    Daly NL; Wilson DT
    Biochem Soc Trans; 2021 Jun; 49(3):1279-1285. PubMed ID: 34156400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
    Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.